{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:48:19Z","timestamp":1790786899995,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T00:00:00Z","timestamp":1500336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T00:00:00Z","timestamp":1500336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The aim of this study is to evaluate the efficacy and safety of sugammadex for reversing neuromuscular blockade in pediatric patients. MEDLINE and other three Databases were searched. Randomized clinical trials were included if they compared sugammadex with neostigmine or placebo in pediatric patients undergoing surgery involving the use of rocuronium or vecuronium. The primary outcome was the time interval from administration of reversal agents to train-of-four ratio (TOFr, T4\/T1)\u2009&gt;\u20090.9. Incidences of any drug-related adverse events were secondary outcomes. Trial inclusion, data extraction, and risk of bias assessment were performed independently. Mean difference and relative risk were used as summary statistics with random effects models. Statistical heterogeneity was assessed by the I<jats:sup>2<\/jats:sup> statistic. Funnel plot was used to detect publication bias. Ten studies with 580 participants were included. Although considerable heterogeneity (I<jats:sup>2<\/jats:sup>\u2009=\u200998.5%) was detected in primary outcome, the results suggested that, compared with placebo or neostigmine, sugammadex can reverse rocuronium-induced neuromuscular blockade more rapidly with lower incidence of bradycardia. No significant differences were found in the incidences of other adverse events. Compared with neostigmine or placebo, sugammadex may reverse rocuronium-induced neuromuscular blockade in pediatric patients rapidly and safely.<\/jats:p>","DOI":"10.1038\/s41598-017-06159-2","type":"journal-article","created":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T13:45:55Z","timestamp":1499867155000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["The efficacy and safety of sugammadex for reversing postoperative residual neuromuscular blockade in pediatric patients: A systematic review"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6758-6590","authenticated-orcid":false,"given":"Guangyu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixiu","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianlong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,18]]},"reference":[{"key":"6159_CR1","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1213\/ANE.0b013e3181e33bd9","volume":"111","author":"GS Murphy","year":"2010","unstructured":"Murphy, G. S. & Brull, S. J. Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth. Analg \n                           111, 120\u2013128, doi:10.1213\/ANE.0b013e3181da832d (2010).","journal-title":"Anesth. Analg"},{"key":"6159_CR2","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1097\/00000542-199210000-00025","volume":"77","author":"DR Bevan","year":"1992","unstructured":"Bevan, D. R., Donati, F. & Kopman, A. F. Reversal of neuromuscular blockade. Anesthesiology \n                           77, 785\u2013805 (1992).","journal-title":"Anesthesiology"},{"key":"6159_CR3","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1093\/bja\/aei240","volume":"95","author":"C Baillard","year":"2005","unstructured":"Baillard, C. et al. Postoperative residual neuromuscular block: a survey of management. Br. J. Anaesth. \n                           95, 622\u2013626, doi:10.1093\/bja\/aei240 (2005).","journal-title":"Br. J. Anaesth."},{"key":"6159_CR4","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1093\/oxfordjournals.bja.a013445","volume":"84","author":"C Baillard","year":"2000","unstructured":"Baillard, C. et al. Residual curarization in the recovery room after vecuronium. Br. J. Anaesth. \n                           84, 394\u2013395 (2000).","journal-title":"Br. J. Anaesth."},{"key":"6159_CR5","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1213\/00000539-199104000-00015","volume":"72","author":"MR Baxter","year":"1991","unstructured":"Baxter, M. R., Bevan, J. C., Samuel, J., Donati, F. & Bevan, D. R. Postoperative neuromuscular function in pediatric day-care patients. Anesth. Analg. \n                           72, 504\u2013508 (1991).","journal-title":"Anesth. Analg."},{"key":"6159_CR6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1053\/sane.2002.34114","volume":"21","author":"LHDJ Booij","year":"2002","unstructured":"Booij, L. H. D. J., de Boer, H. D. & van Egmond, J. Reversal agents for nondepolarizing neuromuscular blockade: Reasons for and development of a new concept. Semin. Anesth. Perio. M \n                           21, 92\u201398, doi:10.1053\/sane.2002.34114 (2002).","journal-title":"Semin. Anesth. Perio. M"},{"key":"6159_CR7","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/00000542-199009000-00008","volume":"73","author":"T Magorian","year":"1990","unstructured":"Magorian, T., Lynam, D., Caldwell, J. & Miller, R. Can early administration of neostigmine, in single or repeated doses, alter the course of neuromuscular recovery from a vecuronium-induced neuromuscular blockade? Anesthesiology \n                           73, 410\u2013414 (1990).","journal-title":"Anesthesiology"},{"key":"6159_CR8","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/BF03006532","volume":"37","author":"OA Meretoja","year":"1990","unstructured":"Meretoja, O. A. & Gebert, R. Postoperative neuromuscular block following atracurium or alcuronium in children. Can. J. Anaesth. \n                           37, 743\u2013746, doi:10.1007\/BF03006532 (1990).","journal-title":"Can. J. Anaesth."},{"key":"6159_CR9","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1213\/01.ANE.0000151159.55655.CB","volume":"100","author":"GS Murphy","year":"2005","unstructured":"Murphy, G. S. et al. Residual paralysis at the time of tracheal extubation. Anesth. Analg. \n                           100, 1840\u20131845, doi:10.1213\/01.ANE.0000151159.55655.CB (2005).","journal-title":"Anesth. Analg."},{"key":"6159_CR10","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1021\/jm011107f","volume":"45","author":"JM Adam","year":"2002","unstructured":"Adam, J. M. et al. Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: synthesis and structure-activity relationships. J. Med. Chem. \n                           45, 1806\u20131816 (2002).","journal-title":"J. Med. Chem."},{"key":"6159_CR11","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1358\/dof.2003.028.04.742715","volume":"28","author":"MQ Zhang","year":"2003","unstructured":"Zhang, M. Q. Drug-specific cyclodextrins: the future of rapid neuromuscular block reversal. Drug. Future. \n                           28, 347\u2013354 (2003).","journal-title":"Drug. Future."},{"key":"6159_CR12","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1097\/00000542-200604000-00009","volume":"104","author":"IF Sorgenfrei","year":"2006","unstructured":"Sorgenfrei, I. F. et al. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study. Anesthesiology \n                           104, 667\u2013674 (2006).","journal-title":"Anesthesiology"},{"key":"6159_CR13","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/00000542-200702000-00016","volume":"106","author":"K Suy","year":"2007","unstructured":"Suy, K. et al. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent. Anesthesiology \n                           106, 283\u2013288, doi:10.1097\/00000542-200702000-00016 (2007).","journal-title":"Anesthesiology"},{"key":"6159_CR14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1213\/01.ane.0000231829.29177.8e","volume":"104","author":"BF Vanacker","year":"2007","unstructured":"Vanacker, B. F. et al. Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane. Anesth. Analg. \n                           104, 563\u2013568, doi:10.1213\/01.ane.0000231829.29177.8e (2007).","journal-title":"Anesth. Analg."},{"key":"6159_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/bja\/aei314","volume":"96","author":"M Shields","year":"2006","unstructured":"Shields, M. et al. Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block. Br. J. Anaesth. \n                           96, 36\u201343, doi:10.1093\/bja\/aei314 (2006).","journal-title":"Br. J. Anaesth."},{"key":"6159_CR16","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1213\/01.ane.0000260135.46070.c3","volume":"104","author":"SB Groudine","year":"2007","unstructured":"Groudine, S. B., Soto, R., Lien, C., Drover, D. & Roberts, K. A randomized, dose-finding, phase II study of the selective relaxant binding drug, Sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block. Anesth. Analg. \n                           104, 555\u2013562, doi:10.1213\/01.ane.0000260135.46070.c3 (2007).","journal-title":"Anesth. Analg."},{"key":"6159_CR17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/01.anes.0000270722.95764.37","volume":"107","author":"HD de Boer","year":"2007","unstructured":"de Boer, H. D. et al. Reversal of rocuronium-induced (1.2 mg\/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study. Anesthesiology \n                           107, 239\u2013244, doi:10.1097\/01.anes.0000270722.95764.37 (2007).","journal-title":"Anesthesiology"},{"key":"6159_CR18","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1097\/01.anes.0000265152.78943.74","volume":"106","author":"HJ Sparr","year":"2007","unstructured":"Sparr, H. J. et al. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics. Anesthesiology \n                           106, 935\u2013943, doi:10.1097\/01.anes.0000265152.78943.74 (2007).","journal-title":"Anesthesiology"},{"key":"6159_CR19","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1097\/ALN.0b013e3181f4182a","volume":"113","author":"SJ Schaller","year":"2010","unstructured":"Schaller, S. J., Fink, H., Ulm, K. & Blobner, M. Sugammadex and Neostigmine Dose-finding Study for Reversal of Shallow Residual Neuromuscular Block. Anesthesiology \n                           113, 1054\u20131060, doi:10.1097\/ALN.0b013e3181f4182a (2010).","journal-title":"Anesthesiology"},{"key":"6159_CR20","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/ALN.0b013e318297ce95","volume":"119","author":"A Pongracz","year":"2013","unstructured":"Pongracz, A., Szatmari, S., Nemes, R., Fulesdi, B. & Tassonyi, E. Reversal of neuromuscular blockade with sugammadex at the reappearance of four twitches to train-of-four stimulation. Anesthesiology \n                           119, 36\u201342, doi:10.1097\/ALN.0b013e318297ce95 (2013).","journal-title":"Anesthesiology"},{"key":"6159_CR21","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/bja\/aev437","volume":"116","author":"N Kaufhold","year":"2016","unstructured":"Kaufhold, N. et al. Sugammadex and neostigmine dose-finding study for reversal of residual neuromuscular block at a train-of-four ratio of 0.2 (SUNDRO20). Br. J. Anaesth. \n                           116, 233\u2013240, doi:10.1093\/bja\/aev437 (2016).","journal-title":"Br. J. Anaesth."},{"key":"6159_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1093\/bja\/83.1.58","volume":"83","author":"DM Fisher","year":"1999","unstructured":"Fisher, D. M. Neuromuscular blocking agents in paediatric anaesthesia. Br. J. Anaesth. \n                           83, 58\u201364 (1999).","journal-title":"Br. J. Anaesth."},{"key":"6159_CR23","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/ALN.0b013e318194caaa","volume":"110","author":"B Plaud","year":"2009","unstructured":"Plaud, B. et al. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients. Anesthesiology \n                           110, 284\u2013294, doi:10.1097\/ALN.0b013e318194caaa (2009).","journal-title":"Anesthesiology"},{"key":"6159_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/00003643-201106001-00490","volume":"28","author":"RG Veiga","year":"2011","unstructured":"Veiga, R. G. et al. Sugammadex reversal efficacy and security vs neostigmine in the rocuronium\u2010induced neuromuscular blockade in paediatric patients. Eur. J. Anaesthesiol. \n                           28, 153 (2011).","journal-title":"Eur. J. Anaesthesiol."},{"key":"6159_CR25","unstructured":"Alvarez-Gomez, J. A. et al. Efficacy and Safety of the Reversal With Sugammadex From Deep Rocuronium-Induced Neuromuscular Blockade in Children, http:\/\/www.asaabstracts.com\/strands\/asaabstracts\/abstract.htm?year=2012&index=16&absnum=2981 (2012)."},{"key":"6159_CR26","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/bja\/aer372","volume":"108","author":"D Gaona","year":"2012","unstructured":"Gaona, D., Carceles, M. D., Veiga, G., Tedesco, M. & Motta, P. Efficacy and safety of the reversal with sugammadex in deep neuromuscular blockade induced by rocuronium in pediatrics. Br. J. Anaesth. \n                           108, 308\u2013309 (2012).","journal-title":"Br. J. Anaesth."},{"key":"6159_CR27","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.bjan.2014.03.001","volume":"64","author":"T Kara","year":"2014","unstructured":"Kara, T. et al. Sugammadex versus neostigmine in pediatric patients: a prospective randomized study. Rev. Bras. Anestesiol \n                           64, 400\u2013405, doi:10.1016\/j.bjan.2014.03.001 (2014).","journal-title":"Rev. Bras. Anestesiol"},{"key":"6159_CR28","first-page":"762","volume":"19","author":"C Ozgun","year":"2014","unstructured":"Ozgun, C., Cakan, T., Baltaci, B. & Basar, H. Comparison of reversal and adverse effects of sugammadex and combination of - Anticholinergic-Anticholinesterase agents in pediatric patients. J. Res. Med. Sci. \n                           19, 762\u2013768 (2014).","journal-title":"J. Res. Med. Sci."},{"key":"6159_CR29","doi-asserted-by":"publisher","first-page":"247","DOI":"10.4103\/1658-354X.154696","volume":"9","author":"AA Ghoneim","year":"2015","unstructured":"Ghoneim, A. A. & El Beltagy, M. A. Comparative study between sugammadex and neostigmine in neurosurgical anesthesia in pediatric patients. Saudi J. Anaesth \n                           9, 247\u2013252, doi:10.4103\/1658-354X.154696 (2015).","journal-title":"Saudi J. Anaesth"},{"key":"6159_CR30","first-page":"447","volume":"32","author":"M El sayed","year":"2016","unstructured":"El sayed, M. & Hassan, S. Does sugammadex facilitate recovery after outpatient tonsillectomy in children? Egyt. J. Anesth. \n                           32, 447\u2013450 (2016).","journal-title":"Egyt. J. Anesth."},{"key":"6159_CR31","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4274\/haseki.3091","volume":"54","author":"D G\u00fczelce","year":"2016","unstructured":"G\u00fczelce, D., Kendigelen, P., T\u00fct\u00fcnc\u00fc, A. \u00c7., Kaya, G. & Alt\u0131nta\u015f, F. Comparison of sugammadex and neostigmine in terms of time to extubation in pediatrics. Med. Bull. Haseki \n                           54, 207\u2013211 (2016).","journal-title":"Med. Bull. Haseki"},{"key":"6159_CR32","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1213\/01.ane.0000492650.20862.e4","volume":"123","author":"RH Mohamad Zaini","year":"2016","unstructured":"Mohamad Zaini, R. H., Penny Tevaraj, J. M., Wan Hassan, W. N. Iberahim, M. I., & Wan Muhd Shukeri, W. F. Comparison between the efficacy of neostigmine versus sugammadex for reversal of rocuronium induced neuromuscular blockade in paediatric patients. Anesth. Analg. \n                           123, 329 (2016).","journal-title":"Anesth. Analg."},{"key":"6159_CR33","unstructured":"Higgins, J. P. & Green, S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0., http:\/\/handbook.cochrane.org (2011)."},{"key":"6159_CR34","doi-asserted-by":"publisher","unstructured":"Hopewell, S., McDonald, S., Clarke, M. & Egger, M. Grey literature in meta-analyses of randomized trials of health care interventions. Cochrane Database Syst. Rev. MR000010, doi:10.1002\/14651858.MR000010.pub3 (2007).","DOI":"10.1002\/14651858.MR000010.pub3"},{"key":"6159_CR35","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1213\/ANE.0b013e3181e8b54b","volume":"111","author":"SJ Brull","year":"2010","unstructured":"Brull, S. J. & Murphy, G. S. Residual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weakness. Anesth. Analg. \n                           111, 129\u2013140, doi:10.1213\/ANE.0b013e3181da8312 (2010).","journal-title":"Anesth. Analg."},{"key":"6159_CR36","doi-asserted-by":"publisher","first-page":"88","DOI":"10.5603\/AIT.2014.0017","volume":"46","author":"B Woloszczuk-Gebicka","year":"2014","unstructured":"Woloszczuk-Gebicka, B., Zawadzka-Glos, L., Lenarczyk, J., Sitkowska, B. D. & Rzewnicka, I. Two cases of the \u201ccannot ventilate, cannot intubate\u201d scenario in children in view of recent recommendations. Anaesthesiol. Intensive Ther \n                           46, 88\u201391, doi:10.5603\/ait.2014.0017 (2014).","journal-title":"Anaesthesiol. Intensive Ther"},{"key":"6159_CR37","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.7150\/ijms.6254","volume":"10","author":"JM Palanca","year":"2013","unstructured":"Palanca, J. M. et al. Sugammadex, a neuromuscular blockade reversal agent, causes neuronal apoptosis in primary cultures. Int. J. Med. Sci. \n                           10, 1278\u20131285, doi:10.7150\/ijms.6254 (2013).","journal-title":"Int. J. Med. Sci."},{"key":"6159_CR38","first-page":"34","volume":"8","author":"NV Matinyan","year":"2013","unstructured":"Matinyan, N. V., Saltanov, A. I. & Mareeva, A. A. Sugammadex use experience in pediatric oncology. Anesteziol. Reanimatol. \n                           8, 34\u201337 (2013).","journal-title":"Anesteziol. Reanimatol."},{"key":"6159_CR39","first-page":"S17","volume":"20","author":"DP Martin","year":"2016","unstructured":"Martin, D. P., Crawford, J., Uffman, J., Michler, R. & Tobias, J. D. Sugammadex and fast-track anesthesia for pediatric cardiac surgery in a developing country. Anaesth. Pain Intensive Care \n                           20, S17\u2013S22 (2016).","journal-title":"Anaesth. Pain Intensive Care"},{"key":"6159_CR40","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/00003643-201406001-00459","volume":"31","author":"A Alonso","year":"2014","unstructured":"Alonso, A., De Boer, H. D. & Booij, L. Reversal of rocuronium-induced neuromuscular block by sugammadex in neonates. Eur. J. Anaesthesiol. \n                           31, 163 (2014).","journal-title":"Eur. J. Anaesthesiol."},{"key":"6159_CR41","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt, G. H. et al. What is \u201cquality of evidence\u201d and why is it important to clinicians? BMJ \n                           336, 995\u2013998, doi:10.1136\/bmj.39490.551019.BE (2008).","journal-title":"BMJ"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06159-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06159-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06159-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T06:52:37Z","timestamp":1671778357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-06159-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,18]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["6159"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-06159-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,18]]},"assertion":[{"value":"15 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5724"}}